Attached files
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of TETRAGENEX PHARMACEUTICALS, INC. (the
“Company”) on Form 10-K for the period ending December 31, 2009 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Martin F. Schacker, Co-Chief Executive Officer, certify, pursuant to 18
U.S.C.ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act,
that:
|
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
TETRAGENEX
PHARMACEUTICALS, INC.
|
||
|
By:
|
/s/ Martin F.
Schacker
|
|
|
Martin
F. Schacker
|
||
|
Co-Chief
Executive Officer
|
||
| April 15, 2010 | ||